Casdin Partners Master Fund, L.P. - 01 Sep 2021 Form 4/A - Amendment Insider Report for BIOLIFE SOLUTIONS INC (BLFS)

Role: 10%+ Owner
Signature: Casdin Partners Master Fund LP, By: Casdin Partners GP, LLC, its General Partner, By: /s/ Eli Casdin, Managing Member
Issuer symbol: BLFS
Transactions as of: 01 Sep 2021
Net transactions value: $0
Form type: 4/A - Amendment
Filing time: 19 May 2023, 20:32:15 UTC
Date Of Original Report: 03 Nov 2021
Previous filing: 04 Aug 2021
Next filing: 06 Apr 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BLFS	Common Stock, par value $.001 per share	Other		+131,428	+1.8%		7,571,535	01 Sep 2021	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported securities were received by Casdin Partners Master Fund, L.P. (the "Master Fund") upon closing of the merger between Sexton Biotechnologies, Inc. ("Sexton") and the Issuer with approximately 10% of the amount deposited into an escrow account for indemnification and post-closing purchase price adjustments. The foregoing description of the merger does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on September 8, 2021, which is incorporated by reference.
F2	The securities are owned directly by the Master Fund and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC, the general partner of the Master Fund, and (iii) Eli Casdin, the managing member of Casdin Capital, LLC and Casdin Partners GP, LLC.

Content

The reported securities were received by Casdin Partners Master Fund, L.P. (the "Master Fund") upon closing of the merger between Sexton Biotechnologies, Inc. ("Sexton") and the Issuer with approximately 10% of the amount deposited into an escrow account for indemnification and post-closing purchase price adjustments. The foregoing description of the merger does not purport to be complete and is subject to and qualified in its entirety by reference to the Issuer's 8-K filed on September 8, 2021, which is incorporated by reference.

The securities are owned directly by the Master Fund and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC, the general partner of the Master Fund, and (iii) Eli Casdin, the managing member of Casdin Capital, LLC and Casdin Partners GP, LLC.

Remarks:

The original Form 4 is being amended to update the beneficial ownership information reported therein. Each Reporting Person disclaims beneficial ownership in the securities reported on this Form 4 except to the extent of its or his pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.